Aquatic Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Aquatic Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,426	Closed	-$902K	–	1406
2025 Q3	$902K	Sell	7,426 -16,208	-69%	-$1.83M	0.02%	701
2025 Q2	$2.47M	Sell	23,634 -23,812	-50%	-$2.52M	0.05%	415
2025 Q1	$5.53M	Buy	47,446 +46,543	+5,154%	+$5.3M	0.14%	195
2024 Q4	$76.4K	Buy	+903	New	+$83K	﹤0.01%	1114
2024 Q3	–	Sell	-5,200	Closed	-$419K	–	1145
2024 Q2	$419K	Buy	+5,200	New	+$385K	0.02%	583
2024 Q1	–	Sell	-14,100	Closed	-$1.12M	–	1226
2023 Q4	$1.12M	Buy	+14,100	New	+$943K	0.03%	449
2023 Q2	–	Sell	-4,500	Closed	-$278K	–	1332
2023 Q1	$278K	Buy	+4,500	New	+$296K	0.02%	522
2022 Q2	–	Sell	-700	Closed	-$29K	–	1197
2022 Q1	$29K	Buy	+700	New	+$21.7K	0.04%	397

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aquatic Capital Management's AXSM Position: Q4 2025 in Review

Aquatic Capital Management sold out of Axsome Therapeutics (AXSM) in Q4 2025, closing a stake of 7,426 shares — an estimated $902K sold.

Aquatic Capital Management first reported a position in AXSM in Q1 2022 and held it in 8 quarters. The position peaked at $5.53M in Q1 2025. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

Aquatic Capital Management reported no remaining Axsome Therapeutics position as of Q4 2025 after selling out during the quarter.
Aquatic Capital Management sold 7,426 Axsome Therapeutics shares in Q4 2025, an estimated $902K.
Aquatic Capital Management first reported a position in Axsome Therapeutics in Q1 2022 and held it in 8 quarters.
Aquatic Capital Management's Axsome Therapeutics position peaked at $5.53M in Q1 2025.
398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.